Clinical Trial Update: A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update from Hoffmann-La Roche evaluating a DPP-4 inhibitor in patients with Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DPP-4 inhibitor (unspecified) (DPP-4 inhibitor)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 2 | Status: COMPLETED